Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate

Gode, Funda; Karagoz, Cigdem; POSACI, CEMAL; Saatli, HASAN; Uysal, Didem; SEÇİL, MUSTAFA; AKDENİZ, BAHRİ

doi:10.1007/s00404-010-1790-9

Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate

Gode F., Karagoz C., POSACI C., Saatli B., Uysal D., SEÇİL M., ...Daha Fazla

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.284, sa.4, ss.923-929, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 284 Sayı: 4
Basım Tarihi: 2011
Doi Numarası: 10.1007/s00404-010-1790-9
Dergi Adı: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.923-929
Anahtar Kelimeler: Polycystic ovary syndrome, Cardiovascular risk, Oral contraceptives, Metabolic risk
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

We aimed to evaluate the alteration of cardiovascular and metabolic risk parameters of polycystic ovary syndrome (PCOS) patients after a 6-month treatment with an oral contraceptive (OC) containing cyproterone acetate (CPA).